Vidcast:  https://youtu.be/RZyXvKmZ6Ho

 

mRNA vaccines trigger protective anti-CoVid antibodies in only 17% of transplant patients compared with close to 100% of the general population.  Johns Hopkins researchers now publish this data from their study of 436 transplant recipients.

 

Moderna vaccine proved the more effective triggering antibodies in 34% compared with the Pfizer product inducing them in only 12%.  Only 10% of those on anti-metabolite immunosuppression produced antibodies compared with 70% of those not receiving antimetabolites.  Younger recipients 39 years and younger were twice a likely as older persons to develop antibodies.

 

Transplant recipients may do better with additional vaccine boosters.  Meanwhile, they must do everything to avoid CoVid infection.

 

https://jamanetwork.com/journals/jama/fullarticle/2777685

 

#CoVid #mrna #moderna #pfizer #antibodies